research and development
Sten Westerberg joins BioInvent
April 26, 2011Research and Development appointment, research and development, sales and marketing
Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …
Trevor Smith to lead Takeda in Europe
April 21, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Novavax appoints Stanley Erck chief executive
April 20, 2011Research and Development appointment, research and development
US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …
Angela Pasma to lead Chiltern’s new Netherlands office
April 1, 2011Research and Development appointment, chiltern, research and development
Contract research organisation Chiltern has expanded its European operations, opening a new office in the Netherlands. The Leiden office will …
Roche appoints Janet Hammond to translational medicine role
March 31, 2011Research and Development appointment, research and development
Janet Hammond has joined Roche to drive the early clinical development strategy for its virology discovery and translational area. She …
Bertrand Lehuu joins Aquapharm
March 24, 2011Research and Development appointment, research and development
Scottish marine biotechnology company Aquapharm Biodiscovery has appointed Bertrand Lehuu as senior VP – pharma business. Bertrand has almost 30 …
Richard Bergström takes DG role at EFPIA
March 18, 2011Research and Development, Sales and Marketing Brian Ager, EFPIA, Richard Bergstrom, appointment, research and development, sales and marketing
European pharma industry association EFPIA has appointed Richard Bergström as its new director general. He takes over from Brian Ager, …
Former Gates Foundation director joins Sanofi
March 14, 2011Research and Development Dr Richard Klausner, Sanofi-Aventis, appointment, research and development
Sanofi-Aventis has appointed a former Gates Foundation director to chair its strategic development and scientific advisory council. Dr Richard Klausner …
Francois Meyer to head up TxCell
March 9, 2011Research and Development Francois Meyer, TxCell, appointment, research and development
French biotech TxCell has appointed François Meyer as chief executive. He has more than 25 years of pharma and biotech …
Boehringer’s Kay O’Hagan moves to Brecon
March 2, 2011Manufacturing and Production, Research and Development Brecon, Kay O'Hagan, appointment, manufacturing and production, research and development
Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …
Friedhelm Felten to head procurement at Merck
March 1, 2011Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development
Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …
Service Insight: Discovery metrics – creating the right balance
February 28, 2011Research and Development Atkinson Cowan, Kinapse, Service Insight, metrics, research and development
SERVICE INSIGHTMetrics can be powerful tools for driving performance in organisations and have proliferated in the pharmaceutical industry over the …
David Redfern appointed ViiV chairman
February 28, 2011Research and Development, Sales and Marketing David Redfern, GSK, GlaxoSmithKline, Pfizer, ViiV, ViiV Healthcare, appointment, research and development, sales and marketing
David Redfern has been appointed as chairman of ViiV Healthcare, the joint GlaxoSmithKline-Pfizer venture focused on HIV.
MPs to question Pfizer management over R&D closure
February 25, 2011Research and Development Kent, Pfizer, Sandwich, Science and Technology Select Committee, research and development
Senior Pfizer executives will appear before MPs next week to answer questions on the closure of the company’s Kent research …
Kieran Murphy to head up life sciences for GE Healthcare
February 23, 2011Research and Development, Sales and Marketing GE Healthcare, Kieran Murphy, appointment, research and development, sales and marketing
GE Healthcare has promoted Kieran Murphy to succeed its current Life Sciences president and chief executive Peter Ehrenheim. Kieran, who …
